HBMN HBM BioVentures

Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors

HBM Healthcare Investments AG / Key word(s): AGMEGM
Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors

17.06.2024 / 17:53 CET/CEST


At today’s ordinary Shareholders’ Meeting of HBM Healthcare Investments Ltd the shareholders approved all proposals submitted by the Board of Directors.

The Chairman of the Board of Directors Hans Peter Hasler and the existing board members Dr Rudolf Lanz, Mario G. Giuliani,  Dr Stella X. Xu and Dr Elaine V. Jones were re-elected for a further one year term. The existing members of the Compensaiton Committee Mario G. Giuliani, Dr Stella X. Xu and Dr Elaine E. Jones were also re-elected for a further one year term.  Furthermore, the shareholders approved the proposed compensation to the Board of Directors and to the Management.

Further, the Shareholders’ Meeting approved a par value repayment of CHF 7.50 per share. The cash payment will be made on 9 August 2024. The registered shares with entitlement to the distribution will be traded for the last time on 6 August 2024 (from 7 August 2024 without, ex-date).

The presentation shown at the Shareholder’s Meeting 2024 can be accessed on the company's website at .

Contact
For further information, please contact Dr Andreas Wicki on 7, or at .



End of Media Release


Language: English
Company: HBM Healthcare Investments AG
Bundesplatz 1
6300 Zug
Switzerland
Phone:
Fax:
E-mail:
Internet:
ISIN: CH0012627250
Valor: 1262725
Listed: SIX Swiss Exchange
EQS News ID: 1926963

 
End of News EQS News Service

1926963  17.06.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1926963&application_name=news&site_id=research_pool
EN
17/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on HBM BioVentures

 PRESS RELEASE

Key Figures 15.11.2024

HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.11.2024 18.11.2024 / 17:47 CET/CEST   in CHF Performance in %   15.11.2024   MTD FYTD CYTD NAV 251.81 0.5 4.5 15.2 Share Price 189.00 0.7 1.5 7.6 Total Net Assets (in million) 1'711       HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - Swit...

HBM Healthcare Investments AG: 1 director

A director at HBM Healthcare Investments AG bought 500 shares at 182.248CHF and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...

 PRESS RELEASE

Key Figures 31.10.2024

HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 31.10.2024 04.11.2024 / 17:47 CET/CEST   in CHF Performance in %   31.10.2024   MTD FYTD CYTD NAV 250.49 2.5 4.0 14.6 Share Price 187.60 -1.0 0.8 6.8 Total Net Assets (in million) 1'704       HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - Swi...

 PRESS RELEASE

Key Figures 15.10.2024

HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.10.2024 16.10.2024 / 17:47 CET/CEST   in CHF Performance in %   15.10.2024   MTD FYTD CYTD NAV 249.16 2.0 3.4 14.1 Share Price 184.60 -2.5 -0.8 5.2 Total Net Assets (in million) 1'697       HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - Sw...

 PRESS RELEASE

Erfolgreicher Börsengang des HBM-Portfoliounternehmens Upstream Bio; K...

HBM Healthcare Investments AG / Schlagwort(e): Börsengang Erfolgreicher Börsengang des HBM-Portfoliounternehmens Upstream Bio; Kapitalaufnahme von USD 255 Millionen 14.10.2024 / 06:30 CET/CEST Upstream Bio (Nasdaq: UPB), ein bisher privates Unternehmen aus dem Portfolio von HBM Healthcare Investments, legte am vergangenen Freitag einen erfolgreichen Start an der Börse hin. Das Unternehmen nahm durch die Ausgabe von 15 Millionen Aktien zu einem Preis von USD 17.00 pro Aktie USD 255 Millionen an neuem Kapital auf. Der Aktienkurs stieg am ersten Handelstag auf USD 22.00 (+29....

ResearchPool Subscriptions

Get the most out of your insights

Get in touch